2023 annual financial data
Atara Biotherapeutics 2023 Operating margin
Direct answer
Operating margin was -3,219.48%.
Operating income was -276,006,000 USD and net income was -276,126,000 USD.
Operating cash flow was -192,977,000 USD.
Get free Atara Biotherapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 8,573,000 USD
- Operating income
- -276,006,000 USD
- Net income
- -276,126,000 USD
- Operating cash flow
- -192,977,000 USD